BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 20093819)

  • 1. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis.
    Kuhlmann MK
    Blood Purif; 2010; 29(2):137-44. PubMed ID: 20093819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hyperphosphatemia.
    Kuhlmann MK
    Hemodial Int; 2006 Oct; 10(4):338-45. PubMed ID: 17014508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of dialysis dose during combination therapy with peritoneal dialysis and hemodialysis.
    Kawanishi H; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2007; 23():135-9. PubMed ID: 17886620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.
    Badve SV; Zimmerman DL; Knoll GA; Burns KD; McCormick BB
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1711-7. PubMed ID: 18815242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal phosphate removal varies by peritoneal dialysis regimen: an underestimated parameter of phosphate control.
    Botelho C; Rodrigues A; Oliveira JC; Cabrita A
    J Nephrol; 2013; 26(1):183-90. PubMed ID: 22460184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphate mass removal during hemodialysis: a comparison between eKT/V-matched conventional and extended dialysis.
    Sampaio MS; Ruzany F; Dorigo DM; Suassuna JH
    Am J Nephrol; 2012; 36(2):121-6. PubMed ID: 22776782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
    Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration.
    Leypoldt JK
    Semin Dial; 2005; 18(5):401-8. PubMed ID: 16191181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST).
    Penne EL; van der Weerd NC; van den Dorpel MA; Grooteman MP; Lévesque R; Nubé MJ; Bots ML; Blankestijn PJ; ter Wee PM;
    Am J Kidney Dis; 2010 Jan; 55(1):77-87. PubMed ID: 19962805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
    Copland M; Komenda P; Weinhandl ED; McCullough PA; Morfin JA
    Am J Kidney Dis; 2016 Nov; 68(5S1):S24-S32. PubMed ID: 27772640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five years' experience of combination therapy: peritoneal dialysis with hemodialysis.
    Kawanishi H; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2002; 18():62-7. PubMed ID: 12402589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary phosphorus and phosphate content of beverages: implications for the treatment of uremic hyperphosphatemia.
    Savica V; Calò LA; Monardo P; Santoro D; Mallamace A; Muraca U; Bellinghieri G
    J Ren Nutr; 2009 Jan; 19(1):69-72. PubMed ID: 19121775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperphosphatemia among end-stage renal disease patients in developing countries: a forgotten issue?
    Afifi A; El-Sayed H; El-Setouhi M; Ahmed H; Khalifa N
    Hemodial Int; 2005 Oct; 9(4):409-15. PubMed ID: 16219062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorus balance with daily dialysis.
    Kooienga L
    Semin Dial; 2007; 20(4):342-5. PubMed ID: 17635826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.
    Lornoy W; De Meester J; Becaus I; Billiouw JM; Van Malderen PA; Van Pottelberge M
    J Ren Nutr; 2006 Jan; 16(1):47-53. PubMed ID: 16414441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.
    Arogundade FA; Ishola DA; Sanusi AA; Akinsola A
    Afr J Med Med Sci; 2005 Sep; 34(3):227-33. PubMed ID: 16749353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ways of intensification of hemodialysis therapy].
    Filiptsev PIa; Kirkhman VV; Timokhov VS
    Ter Arkh; 1988; 60(6):44-7. PubMed ID: 3206368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.